Market Cap (In ILA)
55.83 Million
Revenue (In ILA)
104 Thousand
Net Income (In ILA)
-31.05 Million
Avg. Volume
251.05 Thousand
- Currency
- ILA
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 29.0-53.0
- PE
- -
- EPS
- -
- Beta Value
- 0.716
- ISIN
- IL0011042806
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Avraham Matityahu Fischer M.D.
- Employee Count
- -
- Website
- https://www.cbi.co.il
- Ipo Date
- 2007-06-04
- Details
- Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It invests between $0.5 million and $10 million per company. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional office in Cambridge, Massachusetts. It operates as a former subsidiary of Clal Industries and Investments Ltd.
More Stocks
-
000937
-
NNBRNN, Inc.
NNBR
-
FBK
-
AOT
-
FKKFY
-
SPYRSPYR, Inc.
SPYR
-
MWY
-
WTER